These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2370133)

  • 1. Serotonin S2 receptors and migraine: a study with the selective antagonist ICI 169,369.
    Davies PT; Steiner TJ
    Headache; 1990 May; 30(6):340-3. PubMed ID: 2370133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.
    Cleland PG; Barnes D; Elrington GM; Loizou LA; Rawes GD
    Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First clinical study of the selective 5-HT3 antagonist, granisetron (BRL 43694), in the acute treatment of migraine headache.
    Couturier EG; Hering R; Foster CA; Steiner TJ; Clifford Rose F
    Headache; 1991 May; 31(5):296-7. PubMed ID: 1650335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxocobalamin, a nitric oxide scavenger, in the prophylaxis of migraine: an open, pilot study.
    van der Kuy PH; Merkus FW; Lohman JJ; ter Berg JW; Hooymans PM
    Cephalalgia; 2002 Sep; 22(7):513-9. PubMed ID: 12230592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zatosetron, a 5-HT3 receptor antagonist in a multicenter trial for acute migraine.
    Chappell AS; Bay JM; Botzum GD; Cohen ML
    Neuropharmacology; 1994; 33(3-4):509-13. PubMed ID: 7984290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
    Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ICS 205-930, a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, in the prevention of migraine attacks. A complex answer to a simple question. ICS 205-930 Migraine Study Group.
    Ferrari MD; Wilkinson M; Hirt D; Lataste X; Notter M;
    Pain; 1991 Jun; 45(3):283-291. PubMed ID: 1876437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of tolfenamic acid in the prevention of migraine].
    Vaitkus A; Pauza V
    Medicina (Kaunas); 2002; 38(3):296-303. PubMed ID: 12474702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
    Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
    Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
    Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
    Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo.
    Zeeberg I; Orholm M; Nielsen JD; Honore PL; Larsen JJ
    Acta Neurol Scand; 1981 Dec; 64(6):452-9. PubMed ID: 6753446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT2 receptor antagonists and migraine therapy.
    Mylecharane EJ
    J Neurol; 1991; 238 Suppl 1():S45-52. PubMed ID: 2045831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of serotonin and serotonin receptors in the pathogenesis of migraine and in the mechanisms of action of anti-migraine drugs].
    Amelin AV; Skoromets AA; Ignatov IuD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(7):55-8. PubMed ID: 10957805
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylactic treatments of migraine].
    Massiou H
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S79-86. PubMed ID: 11139754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic advances in migraine.
    Solomon GD
    J Clin Pharmacol; 1993 Mar; 33(3):200-9. PubMed ID: 8385160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
    Klapper J
    Cephalalgia; 1997 Apr; 17(2):103-8. PubMed ID: 9137847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
    Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.